Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.
about
Natural regression of fibrosis in chronic hepatitis BImaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical ApproachCurrent and future directions for treating hepatitis B virus infectionNon-invasive assessment of liver fibrosis in chronic hepatitis B.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis.Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.SASLT practice guidelines for the management of hepatitis B virus.Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Hepatitis B: are non-invasive markers of liver fibrosis reliable?FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.The prognosis and management of inactive HBV carriers.The use of transient elastography in the management of chronic hepatitis B.Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus.The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.JSH Guidelines for the Management of Hepatitis B Virus Infection.A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study.Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis.
P2860
Q26746929-875194C9-161D-462B-A7E1-CE620AE13C35Q26771433-816F3B69-695A-498F-B3F9-6B464EC75EA8Q26851240-415BD46A-D11A-4188-8EC7-BC95C19C44FBQ30427489-D8F5998C-64A9-472D-AA2C-A7E4AA567A5BQ30430774-A9AD6A5F-1775-4BE7-8BFC-555FEC82D1B1Q30472899-F8940D00-8F62-4499-B580-366A9054EB00Q36546657-7C683A05-BD64-42F2-A36A-B18F9AFD3997Q37156348-6A11FE0D-AB99-4DEF-8859-3EC0BB030028Q37634822-92456BA4-B7EE-4F92-82D9-585018E628CDQ37706873-D1F1F871-8929-4DD2-B287-E6F9E996E46BQ38174256-3D88A04A-5266-43F8-8814-45D05EF02360Q38188809-33D2E77B-85E8-4198-A4C8-E173C9B8D4AAQ38240784-D07F8DBF-4F2A-4719-8035-255D1D46B340Q38297230-F14DA604-1FDD-4361-8D44-64B52A140AD1Q38685595-A965B65F-298C-4431-8A02-AF652680B6FAQ39099395-8D38B6E2-98B9-491E-8FB9-B19A9334438CQ39377075-F6894A33-20B1-429C-AB33-1C0AA2E186E5Q42208113-C00C66B4-AC15-4B14-9AE1-0710C9AAEC39Q42223347-C7EF44DE-0F3C-448A-9DF0-7FD0B353A656Q42244740-236A5F79-7C67-4D03-B85E-22D14C9BFF2AQ42263583-280194B6-C992-4753-BF3A-0C62FB0E2F0BQ44595693-8812A6F5-D6B0-464E-AA07-E2476E299B6AQ45760761-E8A18A1F-5A15-489E-BD54-76706AA2891BQ47101834-488CD849-1EED-4A80-86F0-0BC9AFAE313DQ50041595-ACEDF15F-741F-478E-B2DE-150E20ABF26BQ51562701-1520A0BE-2904-4393-BF7E-EA010BA92D1DQ52692830-AFBF8975-E5A3-47E5-A723-AA9B2F4C3589Q55438231-3B3857E9-F6E6-494E-AED6-3793ED608EF6
P2860
Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Transient elastography and bio ...... inactive hepatitis B carriers.
@en
Transient elastography and bio ...... inactive hepatitis B carriers.
@nl
type
label
Transient elastography and bio ...... inactive hepatitis B carriers.
@en
Transient elastography and bio ...... inactive hepatitis B carriers.
@nl
prefLabel
Transient elastography and bio ...... inactive hepatitis B carriers.
@en
Transient elastography and bio ...... inactive hepatitis B carriers.
@nl
P2093
P2860
P1476
Transient elastography and bio ...... inactive hepatitis B carriers.
@en
P2093
P Couzigou
P Trimoulet
P-H Bernard
V de Lédinghen
W Merrouche
P2860
P304
P356
10.1111/J.1365-2036.2010.04547.X
P407
P577
2011-02-01T00:00:00Z